Pseudomonas aeruginosa flagellin as an adjuvant: superiority of a conjugated form of flagellin versus a mixture with a human immunodeficiency virus type 1 vaccine candidate in the induction of immune responses
In the present study, the adjuvant activity of flagellin was compared, in the conjugated and mixed forms, against a peptide vaccine from human immunodeficiency virus type 1 (HIV-1) p24–Nef vaccine candidate. Mice were immunized with the HIV-1 p24–Nef peptide with flagellin in both conjugated and mixed forms. Lymphocyte proliferation, CTL activity, and IL-4 and IFN-γ cytokines were evaluated by bromodeoxyuridine, carboxyfluorescein succinimidyl ester and ELISA methods, respectively. At the same time, the frequency of IFN-γ-producing T-lymphocytes, as well as total and isotype-specific antibodies, were assessed by ELISPOT and indirect ELISA, respectively. Our experimental results showed that the immunized mice with the HIV-1 p24–Nef conjugated or mixed forms of flagellin led to increases in the proliferative responses and Th1 cytokine pattern. The conjugated form of vaccine led to increased CTL activity and a Th1 cytokine pattern of immune responses, as well as an IgM isotype of humoral responses in comparison with the mixed form. The flagellin-conjugated vaccine seems to be more potent in increasing vaccine immunogenicity.
Asadi KaramM. R.,
OloomiM.,
MahdaviM.,
HabibiM.,
BouzariS.2013; Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31:1210–1216 [View Article][PubMed]
AzmiF.,
Ahmad FuaadA. A.,
SkwarczynskiM.,
TothI.2013; Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother 10:778–796[PubMed][CrossRef]
BragaC. J.,
MassisL. M.,
AlencarB. C.,
RodriguesM. M.,
Sbrogio-AlmeidaM. E.,
FerreiraL. C.2008; Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins. Braz J Microbiol 39:44–49 [View Article][PubMed]
CaronG.,
DulucD.,
FrémauxI.,
JeanninP.,
DavidC.,
GascanH.,
DelnesteY.2005; Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-(production by memory CD4+T cells. J Immunol 175:1551–1557 [View Article][PubMed]
FaeziS.,
SafarlooM.,
AmirmozafariN.,
NikokarI.,
SiadatS. D.,
HolderI. A.,
MahdaviM.2014; Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. APMIS 122:115–127 [View Article][PubMed]
FakharzadehS.,
KalanakyS.,
HafiziM.,
GoyaM. M.,
MasoumiZ.,
NamakiS.,
ShakeriN.,
AbbasiM.,
MahdaviM.,
NazaranM. H.2013; The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Vaccine 31:2591–2597 [View Article][PubMed]
GirardA.,
RoquesE.,
MassieB.,
ArchambaultD.2014; Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route. Mol Biotechnol 56:394–407 [View Article][PubMed]
KaramM. R.,
OloomiM.,
MahdaviM.,
HabibiM.,
BouzariS.2013; Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of uropathogenic Escherichia coli
. Mol Immunol 54:32–39 [View Article][PubMed]
LateefS. S.,
GuptaS.,
JayathilakaL. P.,
KrishnanchettiarS.,
HuangJ. S.,
LeeB. S.2007; An improved protocol for coupling synthetic peptides to carrier proteins for antibody production using DMF to solubilize peptides. J Biomol Tech 18:173–176[PubMed]
MahdaviM.,
EbtekarM.,
MahboudiF.,
Khorram KhorshidH.,
RahbarizadehF.,
AzadmaneshK.,
DarabiH.,
PourasgariF.,
HassanZ. M.2009; Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model. Iran J Immunol 6:163–173[PubMed]
MahdaviM.,
EbtekarM.,
Khorram KhorshidH. R.,
AzadmaneshK.,
HartoonianC.,
HassanZ. M.2011; ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses. Immunol Lett 140:14–20 [View Article][PubMed]
NguyenC. T.,
HongS. H.,
UngT. T.,
VermaV.,
KimS. Y.,
RheeJ. H.,
LeeS. E.2013b; Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model. Clin Exp Vaccine Res 2:128–134 [View Article][PubMed]
ParkerR.2002; The global HIV/AIDS pandemic, structural inequalities, and the politics of international health. Am J Public Health 92:343–347 [View Article][PubMed]
PérezO.,
RomeuB.,
CabreraO.,
GonzálezE.,
Batista-DuharteA.,
LabradaA.,
PérezR.,
ReyesL. M.,
RamírezW.,
other authors.
2013; Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform. Front Immunol 4:407 [View Article][PubMed]
SchmidM. A.,
TakizawaH.,
BaumjohannD. R.,
SaitoY.,
ManzM. G.2011; Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 118:4829–4840 [View Article][PubMed]
ThibaultS.,
ImbeaultM.,
TardifM. R.,
TremblayM. J.2009; TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+T cells. Virology 389:20–25 [View Article][PubMed]
Toyota-HanataniY.,
InoueM.,
EkawaT.,
OhtaH.,
IgimiS.,
BabaE.2008; Importance of the major Fli C antigenic site of Salmonella enteritidis as a subunit vaccine antigen. Vaccine 26:4135–4137 [View Article][PubMed]
Pseudomonas aeruginosa flagellin as an adjuvant: superiority of a conjugated form of flagellin versus a mixture with a human immunodeficiency virus type 1 vaccine candidate in the induction of immune responses